Parathyroid cancer

被引:12
作者
Lang, Brian [1 ]
Lo, Chung-Yau [1 ]
机构
[1] Univ Hong Kong, Med Ctr, Queen Mary Hosp, Dept Surg,Div Endocrine Surg, Hong Kong, Hong Kong, Peoples R China
关键词
D O I
10.1016/j.soc.2006.05.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Parathyroid cancer is an uncommon cause of hyperparathyroidism but poses an immense challenge to clinicians. Despite a major evolution in the surgical management of its benign counterparts, the role of perioperative adjuncts in facilitating the management of this uncommon condition remains to be seen. Radical surgical treatment offers the best chance of cure, but for patients who have refractory hypercalcemia secondary to unresectable diseases or metastases, the availability of effective targeted medical therapy may offer a therapeutic option for palliating the debilitating metabolic complication of hypercalcemia and may potentially improve survival.
引用
收藏
页码:573 / +
页数:13
相关论文
共 76 条
[1]   Defection of metastatic parathyroid carcinoma with Tc-99m sestamibi imaging [J].
Al-Sobhi, S ;
Ashari, LH ;
Ingemansson, S .
CLINICAL NUCLEAR MEDICINE, 1999, 24 (01) :21-23
[2]  
Apel RL., 2002, Endocrine Pathology, P103
[3]   Assessment and management of patients with abnormal calcium [J].
Ariyan, CB ;
Sosa, JA .
CRITICAL CARE MEDICINE, 2004, 32 (04) :S146-S154
[4]   Parathyroid carcinoma with metastatic calcification identified by technetium-99m methylene diphosphonate scintigraphy [J].
Aso, Y ;
Sato, A ;
Tayama, K ;
Takanashi, K ;
Satoh, H ;
Takemura, Y .
INTERNAL MEDICINE, 1996, 35 (05) :392-395
[5]   Parathyroid carcinoma [J].
Beus, KS ;
Stack, BC .
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2004, 37 (04) :845-+
[6]   Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis [J].
Block, GA ;
Martin, KJ ;
de Francisco, ALM ;
Turner, SA ;
Avram, MM ;
Suranyi, MG ;
Hercz, G ;
Cunningham, J ;
Abu-Alfa, AK ;
Messa, P ;
Coyne, DW ;
Locatelli, F ;
Cohen, RM ;
Evenepoel, P ;
Moe, SM ;
Fournier, A ;
Braun, J ;
McCary, LC ;
Zani, VJ ;
Olson, KA ;
Drüeke, TB ;
Goodman, WG .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1516-1525
[7]   HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome [J].
Carpten, JD ;
Robbins, CM ;
Villablanca, A ;
Forsberg, L ;
Presciuttini, S ;
Bailey-Wilson, J ;
Simonds, WF ;
Gillanders, EM ;
Kennedy, AM ;
Chen, JD ;
Agarwal, SK ;
Sood, R ;
Jones, MP ;
Moses, TY ;
Haven, C ;
Petillo, D ;
Leotlela, PD ;
Harding, B ;
Cameron, D ;
Pannett, AA ;
Höög, A ;
Heath, H ;
James-Newton, LA ;
Robinson, B ;
Zarbo, RJ ;
Cavaco, BM ;
Wassif, W ;
Perrier, ND ;
Rosen, IB ;
Kristoffersson, U ;
Turnpenny, PD ;
Farnebo, LO ;
Besser, GM ;
Jackson, CE ;
Morreau, H ;
Trent, JM ;
Thakker, RV ;
Marx, SJ ;
Teh, BT ;
Larsson, C ;
Hobbs, MR .
NATURE GENETICS, 2002, 32 (04) :676-680
[8]   Hyperparathyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 gene [J].
Cavaco, BM ;
Guerra, L ;
Bradley, KJ ;
Carvalho, D ;
Harding, B ;
Oliveira, A ;
Santos, MA ;
Sobrinho, LG ;
Thakker, RV ;
Leite, V .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (04) :1747-1752
[9]   Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy - Discussion [J].
Sugg, SL ;
Chen, H ;
McHenry, CR ;
Larson, GM ;
Prinz, RA ;
Siperstein, AE .
SURGERY, 2005, 138 (04) :587-590
[10]   A comprehensive evaluation of perioperative adjuncts during minimally invasive parathyroidectomy - Which is most reliable? [J].
Chen, H ;
Mack, E ;
Starling, JR .
ANNALS OF SURGERY, 2005, 242 (03) :375-383